» Articles » PMID: 28428907

Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature

Overview
Publisher Ubiquity Press
Date 2017 Apr 22
PMID 28428907
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Huntington disease is a fatal, autosomal dominant, neurodegenerative disorder manifest by the triad of a movement disorder, behavioral disturbances, and dementia. At present, no curative or disease modifying therapies exist for the condition and current treatments are symptomatic. Palliative care is an approach to care that focuses on symptom relief, patient and caregiver support, and end of life care. There is increasing evidence of the benefit of palliative care throughout the course of neurodegenerative conditions including Parkinson disease and amyotrophic lateral sclerosis. However, beyond its application at the end of life, little is known about the role of palliative care in Huntington disease.

Methods: In this article, we discuss what is known about palliative care in Huntington disease, specifically related to early disease burden, caregiver burnout, advance care planning, and end of life care.

Results: We provide a review of the current literature and discuss our own care practices.

Discussion: We conclude by discussing questions that remain unanswered and positing ideas for future work in the field.

Citing Articles

Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain.

Howard P, Zou P, Zhang Y, Huang F, Tesic V, Wu C Exp Neurol. 2024; 382:114973.

PMID: 39326820 PMC: 11536509. DOI: 10.1016/j.expneurol.2024.114973.


Palliative care in advanced Huntington's disease: a scoping review.

Boersema-Wijma D, van Duijn E, Heemskerk A, van der Steen J, Achterberg W BMC Palliat Care. 2023; 22(1):54.

PMID: 37138329 PMC: 10155365. DOI: 10.1186/s12904-023-01171-y.


Primary Palliative Care in Huntington's Disease.

Harrison M, Morrissey D, Dalrymple W, DAbreu A, Daly F Mov Disord Clin Pract. 2023; 10(1):55-63.

PMID: 36698999 PMC: 9847290. DOI: 10.1002/mdc3.13589.


Psychosocial Impact of Huntington's Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic.

Hubcikova K, Rakus T, Muhlback A, Benetin J, Bruncvik L, Petrasova Z J Pers Med. 2022; 12(12).

PMID: 36556162 PMC: 9783383. DOI: 10.3390/jpm12121941.


Layers of Loss: A Scoping Review and Taxonomy of HD Caregivers' Spiritual Suffering, Grief/Loss and Coping Strategies.

Leidl B, Fox-Davis D, Walker F, Gabbard J, Marterre B J Pain Symptom Manage. 2022; 65(1):e29-e50.

PMID: 36198334 PMC: 9790041. DOI: 10.1016/j.jpainsymman.2022.09.010.


References
1.
Hudson P, Aranda S, Kristjanson L . Meeting the supportive needs of family caregivers in palliative care: challenges for health professionals. J Palliat Med. 2004; 7(1):19-25. DOI: 10.1089/109662104322737214. View

2.
Schulz R, Beach S . Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA. 1999; 282(23):2215-9. DOI: 10.1001/jama.282.23.2215. View

3.
van Duijn E, Kingma E, van der Mast R . Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci. 2007; 19(4):441-8. DOI: 10.1176/jnp.2007.19.4.441. View

4.
Shoulson I, Fahn S . Huntington disease: clinical care and evaluation. Neurology. 1979; 29(1):1-3. DOI: 10.1212/wnl.29.1.1. View

5.
Connolly S, Galvin M, Hardiman O . End-of-life management in patients with amyotrophic lateral sclerosis. Lancet Neurol. 2015; 14(4):435-42. DOI: 10.1016/S1474-4422(14)70221-2. View